Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Mass Compression from Recurrent Lymphoma Mimicking Lower Extremity Cellulitis.

Li DG, Krajewski KM, Mostaghimi A.

Cureus. 2018 Apr 12;10(4):e2466. doi: 10.7759/cureus.2466.

2.

Radiogenomics in renal cell carcinoma.

Alessandrino F, Shinagare AB, Bossé D, Choueiri TK, Krajewski KM.

Abdom Radiol (NY). 2018 Apr 30. doi: 10.1007/s00261-018-1624-y. [Epub ahead of print]

PMID:
29713740
3.

Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events.

Martini DJ, Hamieh L, McKay RR, Harshman LC, Brandao R, Norton CK, Steinharter JA, Krajewski KM, Gao X, Schutz FA, McGregor B, Bossé D, Lalani AA, De Velasco G, Michaelson MD, McDermott DF, Choueiri TK.

Cancer Immunol Res. 2018 Apr;6(4):402-408. doi: 10.1158/2326-6066.CIR-17-0220. Epub 2018 Feb 1.

PMID:
29437040
4.

The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases.

Viteri Malone MA, Ares GR, De Velasco G, Brandão R, Lin X, Norton C, Simantov R, Moslehi J, Krajewski KM, Choueiri TK, McKay RR.

Clin Genitourin Cancer. 2018 Apr;16(2):e327-e333. doi: 10.1016/j.clgc.2017.11.005. Epub 2017 Dec 6.

PMID:
29361425
5.

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma.

Lalani AA, Xie W, Martini DJ, Steinharter JA, Norton CK, Krajewski KM, Duquette A, Bossé D, Bellmunt J, Van Allen EM, McGregor BA, Creighton CJ, Harshman LC, Choueiri TK.

J Immunother Cancer. 2018 Jan 22;6(1):5. doi: 10.1186/s40425-018-0315-0.

6.

A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma.

Suh CH, Kim KW, Park SH, Shin S, Ahn J, Pyo J, Shinagare AB, Krajewski KM, Ramaiya NH.

Eur Radiol. 2018 Jan;28(1):214-225. doi: 10.1007/s00330-017-4967-9. Epub 2017 Jul 19.

PMID:
28726119
7.

Update on Radiogenomics of Clear Cell Renal Cell Carcinoma.

Alessandrino F, Krajewski KM, Shinagare AB.

Eur Urol Focus. 2016 Dec 15;2(6):572-573. doi: 10.1016/j.euf.2017.01.012. Epub 2017 Feb 23.

PMID:
28723484
8.

Advanced Renal Cell Carcinoma: Role of the Radiologist in the Era of Precision Medicine.

Shinagare AB, Krajewski KM, Braschi-Amirfarzan M, Ramaiya NH.

Radiology. 2017 Aug;284(2):333-351. doi: 10.1148/radiol.2017160343. Review.

PMID:
28723287
9.

Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab.

Moreira RB, Hamieh L, Gjini E, Lako A, Krajewski KM, Yoon CH, Ott PA.

J Immunother Cancer. 2017 Jul 18;5(1):61. doi: 10.1186/s40425-017-0259-9.

10.

Cancer Imaging Fellowship Training: Utility and Added Value in the Modern Era.

Krajewski KM, Howard SA, Shinagare AB, Van den Abbeele AD, Fennessy FM.

J Am Coll Radiol. 2017 Oct;14(10):1345-1348. doi: 10.1016/j.jacr.2017.06.005. Epub 2017 Jul 8. No abstract available.

PMID:
28697959
11.

Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.

Choe J, Braschi-Amirfarzan M, Tirumani SH, Shinagare AB, Kim KW, Ramaiya NH, Krajewski KM.

Abdom Radiol (NY). 2017 Nov;42(11):2710-2724. doi: 10.1007/s00261-017-1195-3. Review.

PMID:
28580540
12.

Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors.

Alessandrino F, Tirumani SH, Krajewski KM, Shinagare AB, Jagannathan JP, Ramaiya NH, Di Salvo DN.

Clin Radiol. 2017 Jul;72(7):521-533. doi: 10.1016/j.crad.2017.04.003. Epub 2017 May 2. Review.

PMID:
28476244
13.

Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

Alessandrino F, Krajewski KM, Tirumani SH, Braschi-Amirfarzan M, Jagannathan JP, Ramaiya NH, Di Salvo DN.

Abdom Radiol (NY). 2017 Jun;42(6):1721-1733. doi: 10.1007/s00261-017-1050-6. Review.

PMID:
28160038
14.

T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes.

Park HS, McIntosh L, Braschi-Amirfarzan M, Shinagare AB, Krajewski KM.

Korean J Radiol. 2017 Jan-Feb;18(1):71-83. doi: 10.3348/kjr.2017.18.1.71. Epub 2017 Jan 5. Review.

15.

Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities.

Krajewski KM, Braschi-Amirfarzan M, DiPiro PJ, Jagannathan JP, Shinagare AB.

Korean J Radiol. 2017 Jan-Feb;18(1):28-41. doi: 10.3348/kjr.2017.18.1.28. Epub 2017 Jan 5. Review.

16.

Radiology Consultation in the Era of Precision Oncology: A Review of Consultation Models and Services in the Tertiary Setting.

DiPiro PJ, Krajewski KM, Giardino AA, Braschi-Amirfarzan M, Ramaiya NH.

Korean J Radiol. 2017 Jan-Feb;18(1):18-27. doi: 10.3348/kjr.2017.18.1.18. Epub 2017 Jan 5. Review.

17.

Current Concepts in the Molecular Genetics and Management of Thyroid Cancer: An Update for Radiologists.

Kelil T, Keraliya AR, Howard SA, Krajewski KM, Braschi-Amirfarzan M, Hornick JL, Ramaiya NH, Tirumani SH.

Radiographics. 2016 Sep-Oct;36(5):1478-93. doi: 10.1148/rg.2016150206. Review.

PMID:
27618325
18.

Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management.

Park KJ, Braschi-Amirfarzan M, DiPiro PJ, Giardino AA, Jagannathan JP, Howard SA, Shinagare AB, Krajewski KM.

Abdom Radiol (NY). 2016 Dec;41(12):2496-2508. Review.

PMID:
27357415
19.

Novel imaging in renal cell carcinoma.

Krajewski KM, Shinagare AB.

Curr Opin Urol. 2016 Sep;26(5):388-95. doi: 10.1097/MOU.0000000000000314. Review.

PMID:
27262139
20.

Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists.

Braschi-Amirfarzan M, Keraliya AR, Krajewski KM, Tirumani SH, Shinagare AB, Hornick JL, Baldini EH, George S, Ramaiya NH, Jagannathan JP.

Radiographics. 2016 May-Jun;36(3):767-82. doi: 10.1148/rg.2016150153. Review.

PMID:
27163593
21.

A New Look at Toxicity in the Era of Precision Oncology: Imaging Findings, Their Relationship With Tumor Response, and Effect on Metastasectomy.

Howard SA, Krajewski KM, Jagannathan JP, Braschi-Amirfarzan M, Tirumani SH, Shinagare AB, Ramaiya NH.

AJR Am J Roentgenol. 2016 Jul;207(1):4-14. doi: 10.2214/AJR.15.15480. Epub 2016 Apr 11. Review.

PMID:
27065346
22.

Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.

Tirumani SH, Souza D, Krajewski KM, Jagannathan JP, Ramaiya NH, Shinagare AB.

Abdom Radiol (NY). 2016 Feb;41(2):295-302. doi: 10.1007/s00261-015-0569-7.

PMID:
26867911
23.

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.

Kwiatkowski DJ, Choueiri TK, Fay AP, Rini BI, Thorner AR, de Velasco G, Tyburczy ME, Hamieh L, Albiges L, Agarwal N, Ho TH, Song J, Pignon JC, Barrios PM, Michaelson MD, Van Allen E, Krajewski KM, Porta C, Pal S, Bellmunt J, McDermott DF, Heng DYC, Gray KP, Signoretti S.

Clin Cancer Res. 2016 May 15;22(10):2445-2452. doi: 10.1158/1078-0432.CCR-15-2631. Epub 2016 Feb 1.

24.

Multimodality imaging of osseous involvement In haematological malignancies.

Keraliya AR, Krajewski KM, Jagannathan JP, Shinagare AB, Braschi-Amirfarzan M, Tirumani SH, Ramaiya NH.

Br J Radiol. 2016;89(1059):20150980. doi: 10.1259/bjr.20150980. Epub 2016 Jan 19. Review.

25.

Cancer Imaging at the Crossroads of Precision Medicine: Perspective From an Academic Imaging Department in a Comprehensive Cancer Center.

Van den Abbeele AD, Krajewski KM, Tirumani SH, Fennessy FM, DiPiro PJ, Nguyen QD, Harris GJ, Jacene HA, Lefever G, Ramaiya NH.

J Am Coll Radiol. 2016 Apr;13(4):365-71. doi: 10.1016/j.jacr.2015.11.002. Epub 2016 Jan 14.

PMID:
26774886
26.

Radiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma.

de Velasco G, Krajewski KM, Albiges L, Awad MM, Bellmunt J, Hodi FS, Choueiri TK.

Cancer Immunol Res. 2016 Jan;4(1):12-7. doi: 10.1158/2326-6066.CIR-15-0197. Epub 2015 Nov 20.

27.

Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation.

Keraliya AR, Rosenthal MH, Krajewski KM, Jagannathan JP, Shinagare AB, Tirumani SH, Ramaiya NH.

AJR Am J Roentgenol. 2015 Oct;205(4):709-19. doi: 10.2214/AJR.15.14459. Review.

PMID:
26397319
28.

Extracutaneous melanomas: a primer for the radiologist.

Keraliya AR, Krajewski KM, Braschi-Amirfarzan M, Tirumani SH, Shinagare AB, Jagannathan JP, Ramaiya NH.

Insights Imaging. 2015 Dec;6(6):707-17. doi: 10.1007/s13244-015-0427-8. Epub 2015 Sep 3.

29.

Imaging of Nervous System Involvement in Hematologic Malignancies: What Radiologists Need to Know.

Keraliya AR, Krajewski KM, Giardino AA, Tirumani SH, Shinagare AB, Ramaiya NH, Jagannathan JP.

AJR Am J Roentgenol. 2015 Sep;205(3):604-17. doi: 10.2214/AJR.14.14092. Review.

PMID:
26295649
30.

Metastatic Chordoma: Report of the Two Cases and Review of the Literature.

Rohatgi S, Ramaiya NH, Jagannathan JP, Howard SA, Shinagare AB, Krajewski KM.

Eurasian J Med. 2015 Jun;47(2):151-4. doi: 10.5152/eurasianjmed.2015.52.

31.

Cancer Imaging Training in the 21st Century: An Overview of Where We Are, and Where We Need To Be.

Howard SA, Krajewski KM, Weissman BN, Seltzer SE, Ramaiya NH, Van den Abbeele AD.

J Am Coll Radiol. 2015 Jul;12(7):714-20. doi: 10.1016/j.jacr.2015.03.044.

PMID:
26143565
32.

MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience.

Baheti AD, Shinagare AB, O'Neill AC, Krajewski KM, Hornick JL, George S, Ramaiya NH, Tirumani SH.

Br J Radiol. 2015 Sep;88(1053):20150085. doi: 10.1259/bjr.20150085. Epub 2015 Jun 25.

33.

Hormonal therapy in oncology: a primer for the radiologist.

Fairchild A, Tirumani SH, Rosenthal MH, Howard SA, Krajewski KM, Nishino M, Shinagare AB, Jagannathan JP, Ramaiya NH.

AJR Am J Roentgenol. 2015 Jun;204(6):W620-30. doi: 10.2214/AJR.14.13604. Review.

PMID:
26001251
34.

Beyond the vascular endothelial growth factor axis: update on role of imaging in nonantiangiogenic molecular targeted therapies in oncology.

Howard SA, Rosenthal MH, Jagannathan JP, Krajewski KM, Shinagare AB, Ramaiya NH, Tirumani SH.

AJR Am J Roentgenol. 2015 May;204(5):919-32. doi: 10.2214/AJR.14.12876. Review.

PMID:
25905926
35.

Esophageal Carcinoma: Current Concepts in the Role of Imaging in Staging and Management.

Tirumani H, Rosenthal MH, Tirumani SH, Shinagare AB, Krajewski KM, Ramaiya NH.

Can Assoc Radiol J. 2015 May;66(2):130-9. doi: 10.1016/j.carj.2014.08.006. Epub 2015 Mar 12. Review.

36.

Anti-VEGF molecular targeted therapies in common solid malignancies: comprehensive update for radiologists.

Tirumani SH, Fairchild A, Krajewski KM, Nishino M, Howard SA, Baheti AD, Rosenthal MH, Jagannathan JP, Shinagare AB, Ramaiya NH.

Radiographics. 2015 Mar-Apr;35(2):455-74. doi: 10.1148/rg.352140119. Review.

PMID:
25763729
37.

Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management.

Kim KW, Shinagare AB, Krajewski KM, Pyo J, Tirumani SH, Jagannathan JP, Ramaiya NH.

Korean J Radiol. 2015 Mar-Apr;16(2):304-13. doi: 10.3348/kjr.2015.16.2.304. Epub 2015 Feb 27.

38.

RECIST 1.1 compared with RECIST 1.0 in patients with advanced renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.

Krajewski KM, Nishino M, Ramaiya NH, Choueiri TK.

AJR Am J Roentgenol. 2015 Mar;204(3):W282-8. doi: 10.2214/AJR.14.13236.

39.

Multimodality Imaging of Tumour Thrombus.

Rohatgi S, Howard SA, Tirumani SH, Ramaiya NH, Krajewski KM.

Can Assoc Radiol J. 2015 May;66(2):121-9. doi: 10.1016/j.carj.2014.11.001. Epub 2015 Feb 3. Review.

40.

Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma.

Grünwald V, McKay RR, Krajewski KM, Kalanovic D, Lin X, Perkins JJ, Simantov R, Choueiri TK.

Eur Urol. 2015 May;67(5):952-8. doi: 10.1016/j.eururo.2014.12.036. Epub 2015 Jan 7.

41.

Vascular toxicity associated with chemotherapy and molecular targeted therapy: what should a radiologist know?

Rohatgi S, Jagannathan JP, Rosenthal MH, Kim KW, Ramaiya NH, Krajewski KM.

AJR Am J Roentgenol. 2014 Dec;203(6):1353-62. doi: 10.2214/AJR.13.11967. Review.

PMID:
25415715
42.

Update on the role of imaging in management of metastatic colorectal cancer.

Tirumani SH, Kim KW, Nishino M, Howard SA, Krajewski KM, Jagannathan JP, Cleary JM, Ramaiya NH, Shinagare AB.

Radiographics. 2014 Nov-Dec;34(7):1908-28. doi: 10.1148/rg.347130090. Review.

43.

Clinical and radiologic features of extraskeletal myxoid chondrosarcoma including initial presentation, local recurrence, and metastases.

Kapoor N, Shinagare AB, Jagannathan JP, Shah SH, Krajewski KM, Hornick JL, Ramaiya NH.

Radiol Oncol. 2014 Jul 10;48(3):235-42. doi: 10.2478/raon-2014-0005. eCollection 2014 Sep.

44.

Teratoma with malignant transformation: report of three cases and review of the literature.

Cabral FC, Krajewski KM, Rosenthal MH, Hirsch MS, Howard SA.

Clin Imaging. 2014 Sep-Oct;38(5):589-93. doi: 10.1016/j.clinimag.2014.04.011. Epub 2014 Apr 28. Review.

PMID:
24908364
45.

Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates.

Choueiri TK, Jacobus S, Bellmunt J, Qu A, Appleman LJ, Tretter C, Bubley GJ, Stack EC, Signoretti S, Walsh M, Steele G, Hirsch M, Sweeney CJ, Taplin ME, Kibel AS, Krajewski KM, Kantoff PW, Ross RW, Rosenberg JE.

J Clin Oncol. 2014 Jun 20;32(18):1889-94. doi: 10.1200/JCO.2013.52.4785. Epub 2014 May 12.

PMID:
24821883
46.

Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT.

Juan YH, Saboo SS, Tirumani SH, Khandelwal A, Shinagare AB, Ramaiya N, Krajewski KM.

AJR Am J Roentgenol. 2014 May;202(5):W422-38. doi: 10.2214/AJR.13.11424. Review.

PMID:
24758677
47.

10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation study.

Krajewski KM, Franchetti Y, Nishino M, Fay AP, Ramaiya N, Van den Abbeele AD, Choueiri TK.

Oncologist. 2014 May;19(5):507-14. doi: 10.1634/theoncologist.2013-0391. Epub 2014 Apr 22.

48.

MRI features of extramedullary myeloma.

Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Munshi NC, Ramaiya NH.

AJR Am J Roentgenol. 2014 Apr;202(4):803-10. doi: 10.2214/AJR.13.10856.

PMID:
24660710
49.

Imaging of uncommon esophageal malignancies.

Tirumani H, Rosenthal MH, Tirumani SH, Shinagare AB, Krajewski KM, Ramaiya NH.

Dis Esophagus. 2015 Aug-Sep;28(6):552-9. doi: 10.1111/dote.12208. Epub 2014 Mar 17. Review.

PMID:
24635682
50.

Clinical problem solving: utility of sonography in oncologic patients.

Cooley C, Nishino M, Jagannathan J, Ramaiya N, Di Salvo D, Krajewski KM.

J Ultrasound Med. 2014 Jan;33(1):9-22. doi: 10.7863/ultra.33.1.9. Review.

Supplemental Content

Loading ...
Support Center